Principal Securities, Inc. Acadia Pharmaceuticals Inc Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Principal Securities, Inc. holds 589 shares of ACAD stock, worth $11,815. This represents 0.0% of its overall portfolio holdings.
Number of Shares
589
Previous 13
4430.77%
Holding current value
$11,815
Previous $239,000
5215.9%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
347Shares Held
163MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$861 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$306 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$242 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$180 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$124 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.25B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...